Vitamin D3 analogue KH1060 combined with TPA synergistically induces mature macrophages in human myeloblastic leukemia ML-1 cells

Anticancer Research

Volumn 19, Issue 2 A, 1999, Pages 1069-1076

  Saito, Yasuhiro ^a   Hatta, Hisako ^a   Mano, Yasunari ^a   Taira, Nozomi ^a   Shimizu, Takahisa ^a   Takeda, Ken ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Differentiation; Human myeloblastic leukemia ML 1 cells; Macrophage; TNF production; TPA; Vitamin D3 analogue

Indexed keywords

1 NAPHTHYL ACETATE ESTERASE; CD14 ANTIGEN; LEXACALCITOL; PHORBOL 13 ACETATE 12 MYRISTATE; TELOMERASE; TUMOR NECROSIS FACTOR; CALCITRIOL; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DRUG DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MACROPHAGE; MONOCYTE; MYELOID LEUKEMIA; PHAGOCYTOSIS; PRIORITY JOURNAL; ACUTE GRANULOCYTIC LEUKEMIA; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; ONCOGENE MYC; PATHOLOGY;

CALCITRIOL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENES, MYC; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MACROPHAGES; TELOMERASE; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032588115     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Koeffler HP: Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implications. Blood 62: 707-721, 1983.
2. Bloch A: Induced cell differentiation in cancer therapy. Cancer Treat Rep 68: 199-205, 1984.
3. Hozumi M: Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Adv Cancer Res 38: 121-169, 1983.
4. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol 98: 391-398, 1984.
5. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y and Suda T: 1α, 25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60). Biochem J 204: 713-719, 1982.
6. 3. Proc Natl Acad Sci USA 78: 4990-4994, 1981.
7. Munker R, Norman A and Koeffler HP: Vitamin D compounds. J Clin Invest 78: 424-430, 1986.
8. 3 analogues. Chem Pharm Bull 34: 4410-4413, 1986.
9. Takeda K, Minowada J, and Bloch A: Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-Tetrade-canoylphorbol-13-acetate, Dimethyl sulfoxide, or 1-β-D-Arabino-fulanosylcytosine. Cancer Res 42: 5152-5158, 1982.
10. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
11. Asaoka Y, Nakamura S, Yoshida K and Nishizuka Y: Protein kinase C, calcium and phospholipid degradation. Trends Biochem Sci 17: 414-417, 1992.
12. Minowada J, Immunology of leukemia cells. In: Gunz F and Henderson E (eds), Leukemia , New York, Grue and Stratton, 1983, pp 119-139.
13. Baehner RL, Nathan DG: Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 278: 971-976, 1968.
14. 3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun 117: 86-92, 1983.
15. 3 inhibits proliferation of human promyelocytic leukemia (HL60) cells and induces monocyte-macrophage differentiation in HL-60 and normal human bone marrow cells. Leuk Res 7: 51-55, 1983.
16. Dodd RC, Cohen MS, Newman SL and Gray TK: Vitamin D metabolites change the phenotype of monoblastic U937 cells. Proc Natl Acad Sci USA 80: 7538-7541, 1983.
17. Olsson I, Gullberg U, Ivhed I and Nilsson K: Induction of differentiation of the human histiocytic lymphoma cell line U937 by 1α, 25-dihydroxycholecalciferol. Cancer Res 43: 5862-5867, 1983.
18. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80: 201-204, 1983.
19. Midland MM, Pluumet Y and Okamura WH: Effect of C20 stereochemistry on the conformational profile of the side chains of vitamin D analogs. Bioorg and Med Chem Lett. 3: 1799-1804, 1993.
20. 3 response element. Leukemia Res 19: 147-158, 1995.
21. 3 are associated with enhanced activation of the vitamin D receptor. J Boil Chem 270: 10551-10558, 1995.
22. Castsagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U and Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847-7851, 1982.
23. Ohno S, Akita Y, Hata A, Osada S, Kubo K, Konno Y, Akimoto K, Mizuno K, Saido T, Kuroki T and Suzuki K: Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC. Adv Enzyme Regul 31: 287-303, 1991.
24. Takashima T, Ueta C, Tsuyuguchi I and Kishimoto S: Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect Immun 58: 3286-3292, 1990
25. Bachwich PR, Lynchm JP, Larrick J, Spengler M and Kunkel SL: Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 125: 421-425, 1986.
26. Clemens MJ, Trayner I, Menaya J: The role of protein kinase C isozymes in the regulation of cell proliferation and differentiation. J Cell Sci 103: 881-887, 1992.
27. GuptaRoy B and Cohen CM: Maturation of murine erythroleukemia cells committed to differentiation requires protein kinase C. J Biol Chem 267: 15326-15333, 1992.
28. Yang KD, Mizobuchi T, Kharbanda SM, Datta R, Huberman E, Kufe DW and Stone RM: All-trans retinoic acid reverses phobol ester resistance in a human myeloid leukemia cell line. Blood 83: 490-496, 1994.
29. Nishikawa M, Komada F, Uemura Y, Hidaka H and Shirakawa S: Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol diester. Cancer Res 50: 621-626, 1990.
30. Aihara H, Asaoka Y, Yoshida K and Nishizuka Y: Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc Natl Acad Sci USA 88: 11062-11066, 1991.
31. Macfarlane DE and Manzel Lorj: Activation of β-isozyme of protein kinase C (PKCβ) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. J Biol Chem 269: 4327-4331, 1994.
32. Hass R, Hirano M, Kharbanda S, Rubin E, Meinherdt G and Kufe D: Resistance to phobol ester-induced differentiation of a U-937 myeloid leukemia cell variant with a signaling defect upstream to Raf-1 kinase. Cell Growth Differ 4: 657-663, 1993.
33. 2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60. Cancer Res 45: 5159-5164, 1985.